Muna Bhanji, Director at Intellia Therapeutics, Inc. (NTLA), sold 3,734 shares at $39.30 ($147K) on 2023-07-06, disclosed to the SEC on 2023-07-10.
Scheduled sale ($147k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.30 | 1,867 | $73K | 50.0% |
| 2 | $39.30 | 1,867 | $73K | 50.0% |
| Total | $39.30 avg | 3,734 | $147K | 100% |
| Filing → |
| CYTK | SELL | 2025-05-15 | $43K | — | Filing → |
| NTLA | SELL | 2025-05-01 | $2K | — | Filing → |
| NTLA | SELL | 2025-01-31 | $3K | — | Filing → |